MYOV - Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q1 2021 Results - Earnings Call Transcript
Myovant Sciences Ltd. (MYOV) Q1 2021 Earnings Conference Call July 28, 2021 08:30 A.M. ET Company Participants Ryan Crowe - VP, IR Dave Marek - CEO Lauren Merendino - CCO Frank Karbe - President and CFO Juan Camilo Arjona Ferreira - Chief Medical Officer Conference Call Participants Jason Butler - JMP Securities Eric Joseph - J.P. Morgan Phil Nadeau - Cowen & Company Brian Skorney - Baird Unidentified Analyst - Evercore ISI Paul Choi - Goldman Sachs Presentation Operator Good day everyone and welcome to Myovant Sciences First Quarter of Fiscal Year 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, Vice President of Investor Relations at Myovant. Please go ahead. Ryan Crowe Thank you, operator. Good morning and thanks for joining us today to review the financial results of Myovant's first quarter of fiscal year
For further details see:
Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q1 2021 Results - Earnings Call Transcript